Cargando…
Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and Prostate Cancer Cells In-Vitro
OBJECTIVE: To study the effect of RITA (MDM2-p53 interaction inhibitor) and its action along with genotoxic drug cisplatin was evaluated on COLO-205 colon cancer and PC-3 prostate cancer cells. METHOD: Various in-vitro parameters to determine cytotoxic and apoptotic potential of RITA with genotoxic...
Autores principales: | Gupta, Amit, Behl, Tapan, Heer, Hem Raj, Deshmukh, Rahul, Sharma, Pyare Lal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062994/ https://www.ncbi.nlm.nih.gov/pubmed/31759358 http://dx.doi.org/10.31557/APJCP.2019.20.11.3341 |
Ejemplares similares
-
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
por: Deben, Christophe, et al.
Publicado: (2015) -
P53/MDM2 Complex-Based Targeted Strategies in Colon Adenocarcinoma
por: Niotis, Athanasios, et al.
Publicado: (2023) -
Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
por: Jiang, Liren, et al.
Publicado: (2019) -
Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
por: Koster, R, et al.
Publicado: (2011) -
Preconditioning offers cardioprotection in hyperlipidemic rat hearts: possible role of Dopamine (D2) signaling
por: Gupta, Varun, et al.
Publicado: (2015)